A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.

@article{Sugrue1990ACO,
  title={A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.},
  author={M. F. Sugrue and P. Mallorga and H. Schwam and J. Baldwin and G. Ponticello},
  journal={Current eye research},
  year={1990},
  volume={9 6},
  pages={
          607-15
        }
}
L-671,152 is a water-soluble, carbonic anhydrase inhibitor structurally similar to MK-927, a carbonic anhydrase inhibitor that, on topical administration, lowers the intraocular pressure (IOP) of experimental animals and humans. L-671,152 was more potent than MK-927 at inhibiting purified, human erythrocyte carbonic anhydrase II in vitro, as reflected in their respective IC50 values of 0.16 nM and 1.19 nM. Both compounds were compared for topical, ocular hypotensive activity in pigmented… Expand
57 Citations
The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
  • M. F. Sugrue
  • Chemistry, Medicine
  • Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
  • 1996
Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors
  • M. F. Sugrue
  • Medicine
  • Progress in Retinal and Eye Research
  • 2000
Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: A multiple-dose efficacy study
Topically active carbonic anhydrase inhibitors for glaucoma.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
MK-927: a topically effective carbonic anhydrase inhibitor in patients.
Carbonic anhydrase inhibitor side effects. Serum chemical analysis.
...
1
2
3
...